David C Marek - Net Worth and Insider Trading
David C Marek Net Worth
The estimated net worth of David C Marek is at least $11 Million dollars as of 2025-05-04. David C Marek is the Principal Executive Officer of Myovant Sciences Ltd and owns about 417,599 shares of Myovant Sciences Ltd (MYOV) stock worth over $11 Million. Details can be seen in David C Marek's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David C Marek has not made any transactions after 2023-01-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David C Marek
David C Marek Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David C Marek owns 2 companies in total, including Axsome Therapeutics Inc (AXSM) , and Myovant Sciences Ltd (MYOV) .
Click here to see the complete history of David C Marek’s form 4 insider trades.
Insider Ownership Summary of David C Marek
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| AXSM | Axsome Therapeutics Inc | 2019-09-04 | Chief Commercial Officer |
| MYOV | Myovant Sciences Ltd | 2023-01-18 | director & Principal Executive Officer |
David C Marek Latest Holdings Summary
David C Marek currently owns a total of 1 stock. David C Marek owns 417,599 shares of Myovant Sciences Ltd (MYOV) as of January 18, 2023, with a value of $11 Million.
Latest Holdings of David C Marek
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MYOV | Myovant Sciences Ltd | 2023-01-18 | 417,599 | 26.98 | 11,266,821 |
Holding Weightings of David C Marek
David C Marek Form 4 Trading Tracker
According to the SEC Form 4 filings, David C Marek has made a total of 5 transactions in Myovant Sciences Ltd (MYOV) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Myovant Sciences Ltd is the sale of 8,037 shares on January 18, 2023, which brought David C Marek around $216,115.
Insider Trading History of David C Marek
- 1
David C Marek Trading Performance
David C Marek Ownership Network
Ownership Network List of David C Marek
Ownership Network Relation of David C Marek
David C Marek Owned Company Details
What does Axsome Therapeutics Inc do?
Who are the key executives at Axsome Therapeutics Inc?
David C Marek is the Chief Commercial Officer of Axsome Therapeutics Inc. Other key executives at Axsome Therapeutics Inc include Chief Financial Officer Nick Pizzie , Chief Operating Officer Mark L. Jacobson , and General Counsel Hunter R. Murdock .
Axsome Therapeutics Inc (AXSM) Insider Trades Summary
Over the past 18 months, David C Marek made no insider transaction in Axsome Therapeutics Inc (AXSM). Other recent insider transactions involving Axsome Therapeutics Inc (AXSM) include a net sale of 80,311 shares made by Mark L. Jacobson , a net sale of 32,323 shares made by Roger Jeffs , and a net sale of 15,000 shares made by Nick Pizzie .
In summary, during the past 3 months, insiders sold 15,000 shares of Axsome Therapeutics Inc (AXSM) in total and bought 0 shares, with a net sale of 15,000 shares. During the past 18 months, 149,147 shares of Axsome Therapeutics Inc (AXSM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 149,147 shares.
Axsome Therapeutics Inc (AXSM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Axsome Therapeutics Inc Insider Transactions
David C Marek Mailing Address
Above is the net worth, insider trading, and ownership report for David C Marek. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, David C Marek's mailing address is: New York Ny 10011.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
